drugset
drugset / Trial / NCT03271983

Pharmacokinetics of Metronidazole Dermal Products

NCT03271983 ↗

Phase 0 Completed 7 enrolled University of Maryland, Baltimore Food and Drug Administration (FDA) · collab
Non-randomizedCrossoverOpen-labelBasic science

Summary

Generate human PK data by collecting data following the application of metronidazole formulations.

Timeline

Start
2019-04-09
Primary completion
2019-10-31
Completion
2019-11-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule — Topical

Indications

No indication recorded.